NDC 33342-087-02 - Rizatriptan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33342-087
- Requested NDC
- 33342-087-02
- Package NDCs from labels
- 33342-087-07, 33342-087-46, 33342-087-12, 33342-087-52, 33342-087-50, 33342-087-72, 33342-087-02, 33342-087-45, 33342-087-41
- Manufacturer
- Macleods Pharmaceuticals Limited
- Effective date
- 2022-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rizatriptan - Macleods Pharmaceuticals Limited | Macleods Pharmaceuticals Limited | 2022-07-01 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33342-087-02 | Rizatriptan | 6 in 1 BLISTER PACK | TABLET, FILM COATED | 6 | 7 | |
| 33342-087-07 | Rizatriptan | 30 in 1 CONTAINER | TABLET, FILM COATED | 30 | 7 | |
| 33342-087-12 | Rizatriptan | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 7 | |
| 33342-087-12 | Rizatriptan | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 33342-087-41 | Rizatriptan | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 7 | |
| 33342-087-45 | Rizatriptan | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 7 | |
| 33342-087-46 | Rizatriptan | 200 in 1 CONTAINER | TABLET, FILM COATED | 200 | 7 | |
| 33342-087-50 | Rizatriptan | 4 in 1 CARTON | TABLET, FILM COATED | 4 | 7 | |
| 33342-087-52 | Rizatriptan | 3 in 1 BLISTER PACK | TABLET, FILM COATED | 3 | 7 | |
| 33342-087-72 | Rizatriptan | 6 in 1 CARTON | TABLET, FILM COATED | 6 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33342-087-02 | EA - Each | 33342-087 | 31681628-355e-470e-ae71-322622e4e5a1 | 1 | 2019-01-24 |
| 33342-087-41 | EA - Each | 33342-087 | 80547782-d6fc-49fc-91c8-fe78fe1ab6ab | 1 | 2019-01-24 |
| 33342-087-45 | EA - Each | 33342-087 | d5783a19-55df-4d1f-ba86-e001fc6c22a3 | 1 | 2019-01-24 |
| 33342-087-50 | EA - Each | 33342-087 | 59084f09-5ae6-43cb-a683-12773e71b91a | 1 | 2015-02-02 |
| 33342-087-52 | EA - Each | 33342-087 | c8d774c2-5553-48ec-9366-3d8ed57f0f40 | 1 | 2018-12-13 |
| 33342-087-72 | EA - Each | 33342-087 | c1755e9d-1add-4b22-9480-435853e9f729 | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 075f47ee-88d1-102b-e063-6394a90acbf8 | 2024-03-25 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Rising Pharma Holdings, Inc. | 2337e102-8df0-4e7f-81d8-5cb86cd48674 | 2024-02-19 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Rising Pharma Holdings, Inc. | 222f77ff-d3f7-40f9-989c-e5902f44ef1e | 2024-02-17 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Aurobindo Pharma Limited | fa0f65b8-96b0-49e4-ac47-9a86fb4aa5f1 | 2024-02-17 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | NuCare Pharmaceuticals,Inc. | 106dd370-c09c-556a-e063-6394a90acfed | 2024-02-02 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 80c124ab-a083-4184-ba6b-199a7681b5d1 | 2023-09-01 | Warnings, Adverse reactions | WR978S7QHH |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 65ae33a2-975f-4a4e-a1a5-42fe451a2434 | 2023-03-23 | Warnings, Adverse reactions | 312840 WR978S7QHH |
| rizatriptan benzoate | RIZATRIPTAN BENZOATE | Macleods Pharmaceuticals Limited | 57ed2505-28f1-4292-b3c3-a49bf0f7c683 | 2023-02-27 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 5001b8cc-8e52-4a00-a830-3b2f79766a03 | 2023-02-06 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 35f26d3c-268b-4114-9b5b-1c2e0b9ddfd5 | 2022-11-22 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Ascend Laboratories, LLC | 07e66554-bc85-4853-9f40-1249617630a9 | 2022-09-30 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | Macleods Pharmaceuticals Limited | 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 | 2022-07-01 | Warnings, Adverse reactions | ANDA203147 33342-088-52 33342-088-46 33342-087-52 33342-088-41 33342-088-72 33342-087-46 33342-088-12 33342-087-12 33342-087-50 33342-087-41 33342-087-07 33342-087-72 33342-088-07 33342-088-50 33342-087-02 33342-088-02 33342-088-45 33342-087-45 33342-088 33342-087 33342008702 314209 312840 fe80232a-c329-47ed-8edd-7786e06f3c08 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 4a5b43f6-a5ea-4d6f-941f-3c19f242c896 | 2022-05-01 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Cipla USA Inc. | f462a507-921c-41c2-93ba-36003b6e8914 | 2022-01-13 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Bionpharma Inc., | 91e160d6-f23f-e5e0-baec-908b2d25ce3c | 2021-03-02 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 3cdeccf6-36dd-4a9e-9687-2f7cce47af5f | 2020-04-08 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | f5520526-1cc5-489f-b142-92f92fec77d3 | 2020-02-01 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Teva Pharmaceuticals USA, Inc. | 4ef60c83-ba48-4134-968b-13800ea9b7f2 | 2019-10-01 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.